Manufacturer: Mylan Laboratories SAS, France.
Product Holder: Abbott Laboratories (M) Sdn. Bhd., Malaysia.
Active Ingredient: Mebeverine hydrochloride 135mg per tablet.
Registration Number: MAL19940428ACZ.
Content: Each pack contains 50 sugar-coated tablets.
Indications: Duspatalin is used for the symptomatic treatment of:
Abdominal pain and cramps associated with irritable bowel syndrome (IBS).
Gastrointestinal spasm secondary to organic diseases.
Administration: Take one tablet three times daily, approximately 20 minutes before meals. Swallow the tablet whole with at least 100 mL of water; do not chew.
Contraindications: Hypersensitivity to mebeverine or any of the excipients.
Precautions: Not recommended for use in children and adolescents under 18 years due to insufficient data on safety and efficacy.
Pregnancy and Lactation: Consult your doctor before use if pregnant or breastfeeding.
Storage: Store below 30°C in a dry place, away from direct sunlight.
Side Effects: May include nausea, dizziness, and allergic reactions.
Malaysia
